Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer
1328.7000 5.10 (0.39%)
NSE Apr 02, 2026 15:31 PM
Volume: 167.9K
 

1328.70
0.39%
Emkay
DLPL reported a steady Q4, with EBITDA beating street/our estimates by 6% and adj PAT improving 34% on YoY basis. Strong performance in core markets (Delhi NCR), buoyed by network expansion, offset the persistent muted performance of Suburban (mid-single digit revenue growth).
Dr. Lal Pathlabs Ltd. has an average target of 1577.00 from 4 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended